7 119 118 Directors’ Report for the year ended 31 March 2023 OTHER STATUTORY INFORMATION (CONTINUED) At the date of this report, there does not exist: i) any charge on the assets of the Group or of the Company that has arisen since the end of the financial year and which secures the liabilities of any other person, or ii) any contingent liability in respect of the Group or of the Company that has arisen since the end of the financial year. No contingent liability or other liability of any company in the Group has become enforceable, or is likely to become enforceable within the period of twelve months after the end of the financial year which, in the opinion of the Directors, will or may substantially affect the ability of the Group and of the Company to meet their obligations as and when they fall due. In the opinion of the Directors, except for the government subsidy income as disclosed in Note 23 to the financial statements, the financial performance of the Group and of the Company for the financial year ended 31 March 2023 have not been substantially affected by any item, transaction or event of a material and unusual nature nor has any such item, transaction or event occurred in the interval between the end of that financial year and the date of this report. SUBSEQUENT EVENT Details of such event is disclosed in Note 36 to the financial statements. AUDITORS The auditors, KPMG PLT, have indicated their willingness to accept re-appointment. The auditors’ remuneration of the Group and of the Company during the year are RM2,751,000 and RM158,000 respectively. The details of auditors’ remuneration are disclosed in Note 23 to the financial statements. Signed on behalf of the Board of Directors in accordance with a resolution of the Directors: Chia Song Kun Director Chia Song Kooi Director Shah Alam Date: 10 July 2023 Statements of financial position as at 31 March 2023 Note Group Company 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 Assets Property, plant and equipment 3 2,209,906 2,187,275 - - Right-of-use assets 4 520,544 475,265 - - Investment properties 5 25,065 26,813 - - Intangible assets 6 125,017 128,108 - - Investment in subsidiaries 7 - - 1,319,172 1,349,424 Investment in associates 8 6,202 2,391 - - Deferred tax assets 9 14,081 11,803 - - Trade and other receivables 10 26,085 24,614 170,068 348,243 Total non-current assets 2,926,900 2,856,269 1,489,240 1,697,667 Biological assets 11 251,914 231,988 - - Inventories 12 955,218 679,302 - - Current tax assets 32,884 28,944 157 - Contract assets 13.1 55,743 53,820 - - Contract costs 13.2 850 1,075 - - Trade and other receivables 10 616,441 495,120 208,006 197,541 Prepayments and other assets 14 66,105 75,487 385 784 Derivative financial assets 15 25,643 4,281 23,551 4,106 Cash and cash equivalents 16 346,499 481,131 18,285 14,915 2,351,297 2,051,148 250,384 217,346 Assets classified as held for sale 17 6,902 49,638 - - Total current assets 2,358,199 2,100,786 250,384 217,346 Total assets 5,285,099 4,957,055 1,739,624 1,915,013 Equity Share capital 620,025 620,025 620,025 620,025 Reserves 2,036,420 1,851,101 486,907 480,257 Equity attributable to owners of the Company 18 2,656,445 2,471,126 1,106,932 1,100,282 Non-controlling interests 231,101 235,281 - - Total equity 2,887,546 2,706,407 1,106,932 1,100,282
RkJQdWJsaXNoZXIy NTkwNzg=